XML 69 R56.htm IDEA: XBRL DOCUMENT v3.3.1.900
Business Segment Information (Details)
$ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2015
USD ($)
Sep. 26, 2015
USD ($)
Jun. 27, 2015
USD ($)
Mar. 28, 2015
USD ($)
Dec. 31, 2014
USD ($)
Sep. 27, 2014
USD ($)
Jun. 28, 2014
USD ($)
Mar. 29, 2014
USD ($)
Dec. 31, 2015
USD ($)
Segment
Dec. 31, 2014
USD ($)
Dec. 31, 2013
USD ($)
Segment Reporting [Abstract]                      
Number of Reportable Segments | Segment                 4    
Segment Reporting Information [Line Items]                      
Revenues $ 4,652.5 $ 4,123.2 $ 4,270.9 $ 3,918.8 $ 4,492.8 $ 4,171.4 $ 4,321.9 $ 3,903.5 $ 16,965.4 $ 16,889.6 $ 13,090.3
Cost of revenues charges                 (9.1) (327.6) (28.6)
Selling, general and administrative charges, net                 (46.3) (130.7) (73.5)
Restructuring and other (costs) income, net                 (115.3) 598.2 (77.7)
Amortization of acquisition-related intangible assets                 (1,314.8) (1,331.7) (763.1)
Operating Income                 2,336.2 2,503.0 1,609.6
Other expense, net                 (399.8) (415.8) (290.1)
Income from Continuing Operations Before Income Taxes                 1,936.4 2,087.2 1,319.5
Depreciation                 373.4 353.1 236.8
Total Assets 40,889.0       42,852.1       40,889.0 42,852.1 31,863.4
Capital Expenditures                 422.9 427.6 282.4
Life Sciences Solutions [Member]                      
Segment Reporting Information [Line Items]                      
Cost of revenues charges                 (2.0) (327.3)  
Selling, general and administrative charges, net                 (13.6) (122.5) (51.7)
Restructuring and other (costs) income, net                 (64.4) 516.4 (4.4)
Total Assets 17,884.3       19,257.0       17,884.3 19,257.0 1,115.5
Capital Expenditures                 85.1 104.4 19.3
Analytical Instruments [Member]                      
Segment Reporting Information [Line Items]                      
Cost of revenues charges                 (0.1) 0.8 (2.9)
Selling, general and administrative charges, net                 0.3 (0.9) (0.6)
Restructuring and other (costs) income, net                 (26.6) (2.5) (20.9)
Total Assets 4,763.1       4,133.3       4,763.1 4,133.3 4,321.4
Capital Expenditures                 59.5 38.1 33.5
Specialty Diagnostics [Member]                      
Segment Reporting Information [Line Items]                      
Cost of revenues charges                 (0.8) (0.9) (24.9)
Selling, general and administrative charges, net                 0.4 (1.5) (12.9)
Restructuring and other (costs) income, net                 (9.7) (17.7) (24.2)
Total Assets 7,183.2       8,047.7       7,183.2 8,047.7 9,086.0
Capital Expenditures                 75.9 84.7 77.9
Laboratory Products and Services [Member]                      
Segment Reporting Information [Line Items]                      
Cost of revenues charges                 (6.2) (0.2) (0.8)
Selling, general and administrative charges, net                 (6.1)    
Restructuring and other (costs) income, net                 (12.6) 121.0 (25.2)
Total Assets 10,266.6       10,875.7       10,266.6 10,875.7 11,523.5
Capital Expenditures                 97.7 102.1 94.7
Corporate and Other [Member]                      
Segment Reporting Information [Line Items]                      
Total Assets [1] $ 791.8       $ 538.4       791.8 538.4 5,817.0
Capital Expenditures                 104.7 98.3 57.0
Total Reportable Segments [Member]                      
Segment Reporting Information [Line Items]                      
Operating Income [2]                 3,821.7 3,694.8 2,552.5
Total Reportable Segments [Member] | Life Sciences Solutions [Member]                      
Segment Reporting Information [Line Items]                      
Revenues                 4,439.4 4,195.7 712.5
Operating Income [2]                 1,336.9 1,214.9 169.7
Depreciation                 146.3 131.6 17.1
Total Reportable Segments [Member] | Analytical Instruments [Member]                      
Segment Reporting Information [Line Items]                      
Revenues                 3,208.2 3,252.2 3,154.2
Operating Income [2]                 612.8 581.1 558.7
Depreciation                 38.9 39.0 41.2
Total Reportable Segments [Member] | Specialty Diagnostics [Member]                      
Segment Reporting Information [Line Items]                      
Revenues                 3,243.9 3,343.6 3,191.7
Operating Income [2]                 872.9 916.0 863.7
Depreciation                 73.7 76.7 73.9
Total Reportable Segments [Member] | Laboratory Products and Services [Member]                      
Segment Reporting Information [Line Items]                      
Revenues                 6,661.5 6,601.5 6,398.8
Operating Income [2]                 999.1 982.8 960.4
Depreciation                 114.5 105.8 104.6
Intersegment Eliminations [Member]                      
Segment Reporting Information [Line Items]                      
Revenues                 (587.6) (503.4) (366.9)
Segment Reconciling Items [Member]                      
Segment Reporting Information [Line Items]                      
Cost of revenues charges                 (9.1) (327.6) (28.6)
Selling, general and administrative charges, net                 (46.3) (130.7) (73.5)
Restructuring and other (costs) income, net                 (115.3) 598.2 (77.7)
Amortization of acquisition-related intangible assets                 $ (1,314.8) $ (1,331.7) $ (763.1)
[1] Corporate assets consist primarily of cash and cash equivalents, short-term investments, property and equipment at the company's corporate offices and assets of the discontinued operations.
[2] Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles.